company

Growth Equity at Goldman Sachs Alternatives

Late-stage private investing arm of Goldman Sachs' alternatives business, which has deployed more than $17bn into companies since 2003.

Current clusters

product1 publisher

Goldman Sachs Alternatives puts $400m into Cyera at the $12bn price set in June

Growth Equity at Goldman Sachs Alternatives has put $400m into Cyera at the valuation the company set in June, its third large round of 2026. What that cheque funds and what a security team can switch on next month are separate questions.

Publishers:thenextweb.com

Reality

Evidence45
Adoption25
Hype gap+30
Incentives80
Confidence55